Cover Image
市場調查報告書

中國的玻尿酸鈉市場分析

Investigation Report on China Sodium Hyaluronate Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333630
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的玻尿酸鈉市場分析 Investigation Report on China Sodium Hyaluronate Market, 2010-2019
出版日期: 2015年06月25日 內容資訊: 英文 35 Pages
簡介

玻尿酸鈉自從打入中國市場之後便急速成長。年度銷售額從2005年的1億人民幣,成長到2014年的2億9,000萬人民幣,年複合成長率達到18.61%。

本報告提供中國的玻尿酸鈉市場相關調查分析,提供您市場規模,市場佔有率,零售價格,主要製造商,市場預測等相關的系統性資訊。

第1章 玻尿酸鈉的相關概念

  • 適應
  • 全球市場銷售情形

第2章 中國的玻尿酸鈉的市場簡介

  • 中國的玻尿酸鈉的專利·核準情況
  • 主要製造商
  • 市場規模

第3章 中國的玻尿酸鈉銷售情形分析

  • 銷售額
  • 銷售額數量

第4章 中國的玻尿酸鈉主要廠商的市場佔有率分析

  • 市場佔有率:銷售額別
  • 市場佔有率:銷售量別

第5章 中國的玻尿酸鈉的各劑型分析

  • 市場佔有率 (各劑型) :銷售額別
  • 市場佔有率 (各劑型) :銷售量別

第6章 中國的玻尿酸鈉的醫院用標準價格

  • URSAPHARM Arzneimittel GmbH Co.KG
  • Shanghai Haohai Biological Technology Co., Ltd
  • Shanghai Jingfeng Pharmaceutical Co., Ltd
  • 參天製藥
  • Bausch & Lomb
  • United Laboratories
  • 生化學工業

第7章 中國的玻尿酸鈉市場主要製造商

  • United Laboratories
  • Bausch & Lomb
  • hanghai Jingfeng Pharmaceutical Co., Ltd
  • Shanghai Haohai Biological Technology Co., Ltd
  • 參天製藥

第8章 中國的玻尿酸鈉市場預測

  • 市場規模的預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1506235

Sodium hyaluronate is a long-chain polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As a major ingredient of synovial fluid and cartilage matrix, sodium hyaluronate can lubricate the joint, protect cartilage of the joint, improve joint contracture and pathological articular fluid. Sodium hyaluronate eye drop is used for the treatment of dry eyes and mechanical lesion to corneal endothelium while sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients.

Currently, only sodium hyaluronate injection and eye drop are available in the market. The raw materials of sodium hyaluronate can be classified into pharmaceutical grade, external grade and edible grade.

Currently, hyaluronate is mainly used as the raw material of artificial synovial fluid and eye drops after eye surgery which together brought in a global sales value of USD 700-800 million. This figure is estimated to reach up to USD 3 billion if its cosmetics are counted too.

In the middle of 1990s, preparations of sodium hyaluronate began to be used in the clinic in China, achieving good efficacy in ophthalmology, orthopaedics and surgery. Sodium hyaluronate develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 290 million in 2014 and CAGR during this period reaching 18.61%. Sodium hyaluronate enjoys a vast demand in China. Seikagaku Corporation (Japan), United Laboratories, Bausch & Lomb, Santen Pharmaceutical Co., Ltd (Japan), Shanghai Jingfeng Pharmaceutical Co., Ltd and URSAPHARM Arzneimittel GmbH Co.KG (GE) all take up certain shares in the market, among which Seikagaku Corporation (Japan) has the largest market share of 29% for sales value in 2014.

Over the last decade, the demand for sodium hyaluronate in the area of health has kept increasing. With the ever-growing demand of life quality and the rapid ageing of urban population (senile diseases like cataract and osteoarthritis, the market size of sodium hyaluronate will continue to expand in China.

Readers can get at least the following information from this report:

  • market size of sodium hyaluronate in China
  • competitive landscape of sodium hyaluronate in Chinese market
  • price of sodium hyaluronate made by different enterprises in China
  • market outlook of sodium hyaluronate in China

The author suggests the following groups of people purchase this report:

  • pharmaceutical enterprises
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Sodium Hyaluronate

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Sodium Hyaluronate in China

  • 2.1. Patent and Approval Status of Sodium Hyaluronate in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Sodium Hyaluronate in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Sodium Hyaluronate in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Sodium Hyaluronate in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Sodium Hyaluronate in Chinese Hospitals in 2014

  • 6.1. URSAPHARM Arzneimittel GmbH Co.KG (GE) (Trade Name: Hycosan)
  • 6.2. Shanghai Haohai Biological Technology Co., Ltd
  • 6.3. Shanghai Jingfeng Pharmaceutical Co., Ltd (Trade Name: Baibei)
  • 6.4. Santen Pharmaceutical Co., Ltd (Japan) (Trade Name: Hialid)
  • 6.5. Bausch & Lomb (Trade Name: Shipeite)
  • 6.6. United Laboratories (Trade Name: Liangjingjing)
  • 6.7. Seikagaku Corporation (Japan) (Trade Name: Artz)

7. Major Manufacturers of Sodium Hyaluronate in Chinese Market, 2010-2014

  • 7.1. United Laboratories
  • 7.2. Bausch & Lomb
  • 7.3. Shanghai Jingfeng Pharmaceutical Co., Ltd
  • 7.4. Shanghai Haohai Biological Technology Co., Ltd
  • 7.5. Santen Pharmaceutical Co., Ltd (Japan)

8. Market Outlook of Sodium Hyaluronate in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Sodium Hyaluronate in China
  • Chart Sales Status of Sodium Hyaluronate in China
  • Chart Sales Value of Sodium Hyaluronate in China, 2010-2014
  • Chart Sales Value of Sodium Hyaluronate in Some Regions in China, 2010-2014
  • Chart Sales Volume of Sodium Hyaluronate in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Sodium Hyaluronate for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Sodium Hyaluronate Made by Seikagaku (Japan) in China, 2010-2014
  • Chart Sales Value and Market Share of Sodium Hyaluronate Made by Santen (Japan) in China, 2010-2014
  • Chart Sales Value and Market Share of Sodium Hyaluronate Made by Bausch & Lomb in China, 2010-2014
  • Chart Sales Value and Market Share of Sodium Hyaluronate Made by URSAPHARM(GE) in China, 2010-2014
  • Chart Sales Value and Market Share of Sodium Hyaluronate Made by Shanghai Jingfeng in China, 2010-2014
  • Chart Sales Value and Market Share of Sodium Hyaluronate Injection in China, 2010-2014
  • Chart Sales Value and Market Share of Sodium Hyaluronate Eye Drop in China, 2010-2014
  • Chart Price of Sodium Hyaluronate Made by URSAPHARM Arzneimittel GmbH Co.KG (GE) in Some Chinese Cities in 2014
  • Chart Price of Sodium Hyaluronate Made by Shanghai Haohai Biological Technology Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Sodium Hyaluronate Made by Shanghai Jingfeng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Sodium Hyaluronate Made by Santen Pharmaceutical Co., Ltd (Japan) in Some Chinese Cities in 2014
  • Chart Price of Sodium Hyaluronate Made by Bausch & Lomb in Some Chinese Cities in 2014
  • Chart Price of Sodium Hyaluronate Made by United Laboratories in Some Chinese Cities in 2014
Back to Top